NASDAQ: FBIO

Fortress Biotech Inc Stock Forecast, Predictions & Price Target

The consensus among 2 Wall Street analysts covering (NASDAQ: FBIO) stock is to Strong Buy FBIO stock.

Out of 2 analysts, 2 (100%) are recommending FBIO as a Strong Buy, 0 (0%) are recommending FBIO as a Buy, 0 (0%) are recommending FBIO as a Hold, 0 (0%) are recommending FBIO as a Sell, and 0 (0%) are recommending FBIO as a Strong Sell.

If you're new to stock investing, here's how to buy Fortress Biotech stock.

(NASDAQ: FBIO) Fortress Biotech's forecast annual revenue growth rate of 25.32% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Fortress Biotech's revenue in 2024 is $84,513,000.On average, 2 Wall Street analysts forecast FBIO's revenue for 2024 to be $1,480,673,811, with the lowest FBIO revenue forecast at $1,252,167,643, and the highest FBIO revenue forecast at $1,709,179,980. On average, 2 Wall Street analysts forecast FBIO's revenue for 2025 to be $2,043,091,352, with the lowest FBIO revenue forecast at $1,496,446,123, and the highest FBIO revenue forecast at $2,589,736,581.

In 2026, FBIO is forecast to generate $3,437,017,451 in revenue, with the lowest revenue forecast at $3,437,017,451 and the highest revenue forecast at $3,437,017,451.

According to 2 Wall Street analysts that have issued a 1 year FBIO price target, the average FBIO price target is $12.50, with the highest FBIO stock price forecast at $15.00 and the lowest FBIO stock price forecast at $10.00.

On average, Wall Street analysts predict that Fortress Biotech's share price could reach $12.50 by Mar 15, 2025. The average Fortress Biotech stock price prediction forecasts a potential upside of 626.74% from the current FBIO share price of $1.72.

(NASDAQ: FBIO) forecast ROE is N/A, which is considered weak.